Product image of Iomeron (Iomeprol) supplied by GNH India

Iomeron

Active Ingredient:
Iomeprol
Origin:
EU

Iomeron (Iomeprol)

Iomeprol, the active ingredient in Iomeron, is a non‑ionic iodinated contrast media presented as a solution for injection for intraarterial, intraarticular, and intravenous use. It provides radiographic contrast by increasing X‑ray attenuation, enabling clearer visualization of vascular structures and tissues during diagnostic imaging procedures. Iomeron is employed in patients undergoing angiography, arthrography, computed tomography and other contrast‑enhanced studies.

GNH India supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Bracco Imaging S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Iomeron is used as a radiographic contrast agent to improve image quality in several diagnostic pathways.

  • Angiography: enhances vascular visualization to aid diagnosis and interventional procedures.
  • Arthrography: delineates joint spaces and soft‑tissue structures for orthopedic assessment.
  • Computed tomography (CT) imaging: increases organ and vessel contrast for more accurate detection of pathology.

How It Works

  • Iomeprol contains iodine atoms that strongly absorb X‑ray photons. When administered, the iodine‑rich solution distributes within the vascular and extracellular compartments, raising the radiodensity of blood vessels and tissues. This differential attenuation creates contrast between structures on radiographic, CT, or fluoroscopic images, allowing clinicians to distinguish anatomical details and pathological changes more clearly.

Side Effects

Adverse reactions may occur following administration of Iomeron.

Common Side Effects

  • Warmth or flushing sensation during injection.
  • Metallic taste in the mouth.
  • Nausea or mild vomiting.
  • Headache or dizziness.
  • Transient urticaria or mild skin rash.
  • Mild increase in serum creatinine.

Serious or Rare Side Effects

  • Severe allergic reaction or anaphylaxis.
  • Acute renal failure, especially in patients with pre‑existing kidney disease.
  • Cardiopulmonary arrest or severe hypotension.
  • Seizures or neurological disturbances.
  • Pulmonary edema.
  • Persistent skin necrosis at injection site.

Precautions & Warnings

Before using Iomeron, clinicians should assess patient risk factors and follow safety guidelines.

  • Renal function assessment: evaluate baseline kidney function and consider alternative agents in severe impairment.
  • Allergy history: screen for prior reactions to iodinated contrast or iodine‑containing substances.
  • Metformin use: discontinue metformin in at‑risk patients with reduced renal clearance before and after administration.
  • Thyroid disease: monitor thyroid function in patients with hyperthyroidism or thyroid nodules.
  • Pregnancy and lactation: use only if the diagnostic benefit outweighs potential fetal or neonatal risk.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Iomeron may interact with certain medications and conditions; awareness helps mitigate risk.

Major Interactions (Avoid)

  • Metformin in patients with impaired renal function: increased risk of lactic acidosis.
  • Radioactive iodine therapy: may interfere with thyroid uptake and treatment efficacy.
  • High‑dose steroids: can mask early signs of an allergic reaction.

Moderate Interactions (Monitor Closely)

  • Diuretics: may exacerbate contrast‑induced nephropathy.
  • ACE inhibitors or ARBs: monitor renal function closely when combined with contrast.
  • Beta‑blockers: may affect hemodynamic response during intra‑arterial injection.

Frequently Asked Questions

Iomeron is an injectable iodinated contrast medium used to enhance the visibility of blood vessels, organs, and tissues during diagnostic imaging procedures such as angiography, arthrography, and computed tomography (CT) scans. By increasing radiodensity, it helps radiologists obtain clearer images for accurate diagnosis.

Iomeprol contains iodine atoms that strongly absorb X‑ray photons. When injected, the iodine‑rich solution distributes in the vascular and extracellular spaces, raising the radiodensity of those areas. This creates a contrast between structures on X‑ray‑based images, allowing better delineation of anatomy and pathology.

The dose of Iomeron is determined by the prescribing clinician based on the specific imaging study, patient weight, renal function, and the required level of contrast enhancement. Healthcare providers calculate the appropriate volume and concentration for each individual case.

Safety data for Iomeron in pregnancy and lactation are limited. It should be used only when the diagnostic benefit outweighs potential risks to the fetus or infant. Clinicians must evaluate each case carefully and discuss possible concerns with the patient.

To order Iomeron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Iomeron is a non‑ionic, low‑osmolality iodinated contrast medium, which generally offers a lower incidence of adverse reactions compared with older high‑osmolality agents. Its iodine concentration provides strong radiographic enhancement while maintaining a favorable safety profile for most patients.

Iomeron should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Before use, allow the solution to reach room temperature if required, and inspect the vial for any particulate matter or discoloration.

Iomeron is administered by a qualified healthcare professional via intra‑arterial, intra‑articular, or intravenous injection, depending on the imaging procedure. The injection rate and volume are tailored to the specific diagnostic protocol and patient characteristics.

Serious risks include severe allergic reactions such as anaphylaxis, acute renal failure especially in patients with pre‑existing kidney disease, and cardiovascular events like hypotension or cardiopulmonary arrest. Immediate medical attention is required if any of these events occur.

Iomeron should be avoided in patients with a known hypersensitivity to iodinated contrast media, those with severe uncontrolled asthma, or individuals with significant renal impairment where alternative imaging strategies are available. Clinicians must assess each patient’s risk before administration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.